-
Mazagon Dock
3,149.70 3,047.00(%) -
Reliance Industr
1,411.85 1,608.95(%) -
Garden Reach Sh.
1,855.00 890.05(%) -
Bajaj Finance
8,560.00 6,376.55(%) -
Cochin Shipyard
1,600.40 1,169.00(%) -
Torrent Pharma.
3,360.00 3,589.95(%) -
Tata Motors
641.10 542.55(%) -
Hind.Aeronautics
4,466.00 3,045.95(%) -
Paras Defence
1,469.00 1,592.75(%) -
Samvardh. Mothe.
131.75 107.30(%) -
Data Pattern
2,459.05 1,350.50(%) -
IndusInd Bank
810.40 605.40(%) -
Varun Beverages
507.45 419.40(%) -
Bharat Electron
312.50 221.00(%) -
Trent
5,134.00 4,058.45(%) -
Hitachi Energy
14,879.00 16,534.50(%) -
Sonata Software
417.90 762.00(%) -
ICICI Bank
1,424.00 1,051.50(%) -
Tech Mahindra
1,510.60 1,807.40(%) -
HDFC Bank
1,936.40 1,977.95(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Pfizer Ltd Pharmaceuticals - Multinational
- MNC Associate
- BSE Code : 434.0
- ISIN : INE182A01018
-
Today’s Low
4,211.00 -
Today’s High
4,297.80

-
Open
4,295.50 -
Perv Close
4,274.10 -
52W Low
3,701.00 -
52W High
6,451.15
Key Indicators
-
P/E(TTM)
31.66
-
Mar.Cap (₹Cr.)
19,526.96
-
Div & Yield %
0.82
-
Book Value(₹)
819.90
-
Debt-Equity Ratio
-0.13
-
AGM Date
29-Apr-2025
-
EPS
134.55
-
P/E Ratio
31.66
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
19,526.96
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
45.75
-
BV (₹)
819.90
-
Sales( ₹ in Cr.)
2,193.17
-
NP (in Cr.)
547.71
-
NP Var(%)
-9.0
-
Div%
350.0
-
CPS (₹)
133.30
-
EPS (₹)
119.70
-
Traded Value (₹ in Lakhs)
19,486.02
-
52 Week High
6,451.15
-
52 Week Low
3,701.00
-
Price BSE
4259.0
-
Price NSE
4,268.00
-
Market Capital( in Cr.)
19,486.02
-
P/C Ratio
31.90
-
P/E Ratio
35.60
-
Price Vs.BV
119.70
-
24-Feb-2025( 02:30)
Hot Pursuit - Volum... - <p>Triveni Engineering and Ind...
-
24-Feb-2025( 11:00)
Hot Pursuit - Volum... - <p>Century Plyboards (India) L...
-
21-Feb-2025( 03:25)
Hot Pursuit - Pfize... - The agreement is for a period...
-
14-Feb-2025( 12:26)
Corporate News - Pfize... - Pfizer announced that Sunil La...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 2,193.17 | 2,424.76 | 2,610.99 | 2,238.55 | 2,151.65 | 2,081.50 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 2,193.17 | 2,424.76 | 2,610.99 | 2,238.55 | 2,151.65 | 2,081.50 |
Other Income | 188.46 | 134.05 | 62.65 | 81.12 | 184.02 | 167.39 |
Stock Adjustments | 11.82 | -56.48 | 72.90 | -14.35 | 36.62 | 90.88 |
Total Income | 2,393.45 | 2,502.33 | 2,746.54 | 2,305.32 | 2,372.29 | 2,339.77 |
EXPENDITURE : | ||||||
Raw Materials | 804.39 | 817.19 | 1,020.93 | 783.39 | 829.02 | 838.78 |
Power and Fuel Cost | 3.98 | 6.51 | 5.67 | 5.79 | 11.04 | 11.45 |
Employee Cost | 347.80 | 331.68 | 403.67 | 361.06 | 364.51 | 323.84 |
Other Manufacturing Expenses | 51.17 | 51.63 | 59.81 | 60.26 | 54.26 | 62.54 |
Selling and Administration Expenses | 317.96 | 298.03 | 310.77 | 268.67 | 319.66 | 335.32 |
Miscellaneous Expenses | 44.37 | 54.29 | 47.10 | 32.63 | 37.06 | 34.82 |
Employee Benefit Expenses | 347.80 | 331.68 | 403.67 | 361.06 | 364.51 | 323.84 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,569.67 | 1,559.33 | 1,847.95 | 1,511.80 | 1,615.55 | 1,606.75 |
Operating Profit | 823.78 | 943.00 | 898.59 | 793.52 | 756.74 | 733.02 |
Interest | 15.43 | 13.48 | 10.70 | 15.39 | 11.01 | 1.72 |
Gross Profit | 808.35 | 929.52 | 887.89 | 778.13 | 745.73 | 731.30 |
Depreciation | 62.28 | 105.51 | 115.00 | 109.41 | 103.24 | 71.39 |
Profit Before Tax | 746.07 | 824.01 | 772.89 | 668.72 | 642.49 | 659.91 |
Current Tax | 158.63 | 251.99 | 196.26 | 183.63 | 133.20 | 243.77 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 36.11 | -51.91 | -35.93 | -12.52 | 0.16 | -12.91 |
Reported Net Profit | 551.33 | 623.93 | 612.56 | 497.61 | 509.13 | 429.05 |
Extraordinary Items | 3.62 | 22.95 | 1.13 | 0.06 | -0.80 | 0.01 |
Adjusted Net Profit | 547.71 | 600.98 | 611.43 | 497.55 | 509.93 | 429.04 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 1,460.05 | 1,133.47 | 681.03 | 1,693.08 | 1,308.04 | 989.29 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 182.99 | 297.35 | 160.12 | 1,509.66 | 124.09 | 110.30 |
P & L Balance carried down | 1,828.39 | 1,460.05 | 1,133.47 | 681.03 | 1,693.08 | 1,308.04 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 350.00 | 700.00 | 350.00 | 350.00 | 3,300.00 | 225.00 |
Dividend Per Share(Rs) | 35.00 | 70.00 | 35.00 | 35.00 | 330.00 | 22.50 |
Earnings Per Share-Unit Curr | 120.51 | 136.38 | 133.89 | 108.77 | 111.29 | 93.78 |
Earnings Per Share(Adj)-Unit Curr | 120.51 | 136.38 | 133.89 | 108.77 | 111.29 | 93.78 |
Book Value | 785.91 | 701.05 | 626.10 | 523.07 | 742.18 | 658.22 |
Book Value(Adj)-Unit Curr | 785.91 | 701.05 | 626.10 | 523.07 | 742.18 | 658.22 |